Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ECL-Lecanemab in Alzheimer's Disease
NCT07688460Phase 4Recruiting
- Sponsor
- The Fourth Affiliated Hospital of Zhejiang University School of Medicine
- Start
- Jul 2026
- Primary completion
- Mar 2029
- Countries
- 1
01
Overview
A Phase 4 trial of lecanemab in Alzheimer's disease (AD), sponsored by The Fourth Affiliated Hospital of Zhejiang University School of Medicine. Started Jul 2026; status: recruiting.
02
Drugs
lecanemab
03
Conditions
Alzheimer's disease (AD)
Beyond the preview
Go deeper on NCT07688460.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07688460.